BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3579320)

  • 1. Brain mitochondrial cytochrome P-450scc: spectral and catalytic properties.
    Walther B; Ghersi-Egea JF; Minn A; Siest G
    Arch Biochem Biophys; 1987 May; 254(2):592-6. PubMed ID: 3579320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol sulfate inhibits adrenal mitochondrial cholesterol side chain cleavage at a site distinct from cytochrome P-450scc. Evidence for an intramitochondrial cholesterol translocator.
    Lambeth JD; Xu XX; Glover M
    J Biol Chem; 1987 Jul; 262(19):9181-8. PubMed ID: 3597410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P-450 of adrenal mitochondria. Spin states as detected by difference spectroscopy.
    Jefcoate CR
    J Biol Chem; 1975 Jun; 250(12):4663-70. PubMed ID: 167000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen increases precursor for pregnenolone synthesis with temperature-sensitive occupancy of P-450scc in mitochondria of rabbit corpus luteum.
    Holt JA; Wittmaack FM; Schreiber JR; Ghosh DK; Menon KM
    Endocrinology; 1988 May; 122(5):1948-57. PubMed ID: 2834180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand modification of corpus luteum mitochondrial cytochrome P-450 spectra and cholesterol monooxygenation: an assay of enzyme-specific inhibitors.
    Uzgiris VI; Graves PE; Salhanick HA
    Biochemistry; 1977 Feb; 16(4):593-600. PubMed ID: 836802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism for control of hydroxymethylglutaryl-coenzyme A reductase and cytochrome P-450 side chain cleavage message and enzyme in the corpus luteum.
    Puryear TK; McLean MP; Khan I; Gibori G
    Endocrinology; 1990 Jun; 126(6):2910-8. PubMed ID: 2351103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of electron transfer from adrenodoxin to cytochrome P-450scc by chemical modification with pyridoxal 5'-phosphate: identification of adrenodoxin-binding site of cytochrome P-450scc.
    Tsubaki M; Iwamoto Y; Hiwatashi A; Ichikawa Y
    Biochemistry; 1989 Aug; 28(17):6899-907. PubMed ID: 2819041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol side-chain cleavage activity in rat fetal gonads: a limiting step for ovarian steroidogenesis.
    Rouiller V; Gangnerau MN; Vayssiere JL; Picon R
    Mol Cell Endocrinol; 1990 Aug; 72(2):111-20. PubMed ID: 2178100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of cholesterol side chain cleavage by active site directed antibody to corpus luteum cytochrome P-450.
    Kashiwagi K; MacDonald AB; Salhanick HA
    J Biol Chem; 1982 Mar; 257(5):2212-7. PubMed ID: 6895894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion of cholesterol to pregnenolone mobilizes cytochrome P-450 in the inner membrane of adrenocortical mitochondria: protein rotation study.
    Ohta Y; Mitani F; Ishimura Y; Yanagibashi K; Kawamura M; Kawato S
    J Biochem; 1990 Jan; 107(1):97-104. PubMed ID: 2332425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 22-Ketocholesterol. A potent competitive inhibitor of cytochrome P-450scc-dependent side-chain cleavage of cholesterol.
    Lambeth JD
    Mol Pharmacol; 1983 May; 23(3):743-7. PubMed ID: 6688121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of the active site of cytochrome P-450scc with a high-affinity spin-labeled inhibitor.
    Seeley D; Schleyer H; Kashiwagi K; Cooper D; Salhanick HA
    Biochemistry; 1987 Mar; 26(5):1270-5. PubMed ID: 3032247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of steroids in pancreas: evidence of cytochrome P-450scc activity.
    Morales A; Cuéllar A; Ramírez J; Vilchis F; Díaz-Sánchez V
    Pancreas; 1999 Jul; 19(1):39-44. PubMed ID: 10416690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electron transfer to cytochrome P-450scc limits cholesterol-side-chain-cleavage activity in the human placenta.
    Tuckey RC; Woods ST; Tajbakhsh M
    Eur J Biochem; 1997 Mar; 244(3):835-9. PubMed ID: 9108254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of enzymatic activity and difference spectra of cytochrome P-450 from various sources by cholesterol side chain cleavage inhibitors.
    Graves PE; Uzgiris VI; Salhanick HA
    Steroids; 1980 May; 35(5):543-59. PubMed ID: 6893091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of an adrenal cytochrome P-450 (P-450SCC) for the side chain cleavage of cholesterol.
    Takikawa O; Gomi T; Suhara K; Itagaki E; Takemori S; Katagiri M
    Arch Biochem Biophys; 1978 Sep; 190(1):300-6. PubMed ID: 708074
    [No Abstract]   [Full Text] [Related]  

  • 17. Purification and comparative characterization of cytochrome P-450scc from porcine adrenocortical mitochondria.
    Iwahashi K; Tsubaki M; Miyatake A; Ichikawa Y
    Int J Biochem; 1991; 23(9):901-9. PubMed ID: 1773895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereoselective inhibition of cholesterol side chain cleavage by enantiomers of aminoglutethimide.
    Uzgiris VI; Whipple CA; Salhanick HA
    Endocrinology; 1977 Jul; 101(1):89-92. PubMed ID: 862564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunofluorescent probing of the mitochondrial cholesterol side-chain cleavage cytochrome P-450 expressed in differentiating granulosa cells in culture.
    Goldring NB; Farkash Y; Goldschmit D; Orly J
    Endocrinology; 1986 Dec; 119(6):2821-32. PubMed ID: 3096698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-linking studies of the cholesterol hydroxylation system from bovine adrenocortical mitochondria.
    Turko IV; Adamovich TB; Kirillova NM; Usanov SA; Chashchin VL
    Biochim Biophys Acta; 1989 Jun; 996(1-2):37-42. PubMed ID: 2736257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.